I am very pleased to introduce the latest article, “How To Diagnose Benign Bone Tumors In The Lower Extremity,” in our CE series. This series, brought to you by HMP Communications, consists of regular CE activities that qualify for one continuing education contact hour (.1 CEU). Readers will not be required to pay a processing fee for this course.
Benign bone tumors in the lower extremity range from the relatively common Dupuytren’s exostosis to enchondromas and giant cell tumors. Bradley Bakotic, DPM, DO, provides a thorough review of various benign bone tumors that one may see in the feet. He offers key insights on the clinical presentation of these lesions and discusses what diagnostic signs clinicians should look for on radiographs.
At the end of this article, you’ll find a nine-question exam. Please mark your responses on the enclosed postcard and return it to HMP Communications. This course will be posted on Podiatry Today’s Web site (www.podiatrytoday.com) roughly one month after the publication date. I hope this CE series contributes to your clinical skills.
Jeff A. Hall
INSTRUCTIONS: Physicians may receive one continuing education contact hour (.1 CEU) by reading the article on pg. 67 and successfully answering the questions on pg. 74. Use the enclosed postcard to submit your answers or log on to www.podiatrytoday.com and respond electronically.
ACCREDITATION: HMP Communications, LLC is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.
DESIGNATION: This activity is approved for 1 continuing education contact hour or .1 CEU.
DISCLOSURE POLICY: All faculty participating in Continuing Education programs sponsored by HMP Communications, LLC are expected to disclose to the audience any real or apparent conflicts of interest related to the content of their presentation.
DISCLOSURE STATEMENTS: Dr. Bakotic has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of his presentation.
GRADING: Answers to the CE exam will be graded by HMP Communications, LLC. Within 60 days, you will be advised that you have passed or failed the exam. A score of 70 percent or above will comprise a passing grade. A certificate will be awarded to participants who successfully complete the exam.
TARGET AUDIENCE: Podiatrists.
RELEASE DATE: May 2004.
EXPIRATION DATE: May 31, 2005.
LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to:
• differentiate between benign bone tumors based on clinical characteristics and diagnostic imaging;
• discuss the frequency, etiology and clinical progression of Dupuytren’s exostosis;
• describe the radiologic features of aneurysmal bone cysts and chondroblastomas; and
• discuss the key clinical characteristics of giant cell tumors and appropriate staging of these tumors.
Sponsored by HMP Communications, LLC.